Ligand id: 320

Name: atropine

IUPHAR Pharmacology Education Project (PEP) logo

View more information in the IUPHAR Pharmacology Education Project: atropine

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 4
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 49.77
Molecular weight 289.17
XLogP 3.54
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

1. Buckley NJ, Bonner TI, Buckley CM, Brann MR. (1989)
Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells.
Mol Pharmacol, 35: 469-476. [PMID:2704370]
2. Cheng K, Khurana S, Chen Y, Kennedy RH, Zimniak P, Raufman JP. (2002)
Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist.
J Pharmacol Exp Ther, 303: 29-35. [PMID:12235229]
3. Christopoulos A, Pierce TL, Sorman JL, El-Fakahany EE. (1998)
On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor.
Mol Pharmacol, 53: 1120-1130. [PMID:9614217]
4. Dowling MR, Charlton SJ. (2006)
Quantifying the association and dissociation rates of unlabelled antagonists at the muscarinic M(3) receptor.
Br J Pharmacol, 148: 927-937. [PMID:16847442]
5. Fruchart-Gaillard C, Mourier G, Marquer C, Ménez A, Servent D. (2006)
Identification of various allosteric interaction sites on M1 muscarinic receptor using 125I-Met35-oxidized muscarinic toxin 7.
Mol Pharmacol, 69: 1641-1651. [PMID:16439611]
6. Hirose H, Aoki I, Kimura T, Fujikawa T, Numazawa T, Sasaki K, Sato A, Hasegawa T, Nishikibe M, Mitsuya M, Ohtake N, Mase T, Noguchi K. (2001)
Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
J Pharmacol Exp Ther, 297: 790-797. [PMID:11303071]
7. Huang F, Buchwald P, Browne CE, Farag HH, Wu WM, Ji F, Hochhaus G, Bodor N. (2001)
Receptor binding studies of soft anticholinergic agents.
AAPS PharmSci, 3: E30-E30. [PMID:12049493]
8. Kashihara K, Varga EV, Waite SL, Roeske WR, Yamamura HI. (1992)
Cloning of the rat M3, M4 and M5 muscarinic acetylcholine receptor genes by the polymerase chain reaction (PCR) and the pharmacological characterization of the expressed genes.
Life Sci, 51: 955-971. [PMID:1325587]
9. Kovacs I, Yamamura HI, Waite SL, Varga EV, Roeske WR. (1998)
Pharmacological comparison of the cloned human and rat M2 muscarinic receptor genes expressed in the murine fibroblast (B82) cell line.
J Pharmacol Exp Ther, 284: 500-507. [PMID:9454790]
10. Maksay G, Laube B, Betz H. (1999)
Selective blocking effects of tropisetron and atropine on recombinant glycine receptors.
J. Neurochem., 73 (2): 802-6. [PMID:10428078]
11. Nelson CP, Nahorski SR, Challiss RA. (2006)
Constitutive activity and inverse agonism at the M2 muscarinic acetylcholine receptor.
J Pharmacol Exp Ther, 316: 279-288. [PMID:16188951]
12. Peralta EG, Ashkenazi A, Winslow JW, Smith DH, Ramachandran J, Capon DJ. (1987)
Distinct primary structures, ligand binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors.
EMBO J., 6: 3923-3929. [PMID:3443095]
13. Smith CM, Wallis RM. (1997)
Characterisation of [3H]-darifenacin as a radioligand for the study of muscarinic M3 receptors.
J. Recept. Signal Transduct. Res., 17: 177-184. [PMID:9029489]
14. Yang Z, Ney A, Cromer BA, Ng HL, Parker MW, Lynch JW. (2007)
Tropisetron modulation of the glycine receptor: femtomolar potentiation and a molecular determinant of inhibition.
J. Neurochem., 100 (3): 758-69. [PMID:17181559]